Waregem (Belgium) / Rotterdam (the Netherlands)[1], 16 December 2013 – Euronext N.V., a wholly owned subsidiary of IntercontinentalExchange Group, Inc. (NYSE: ICE), will introduce options on the shares of Arseus (option trading symbol: RCU). The options will be available as of 16 December 2013 on the derivatives market of Euronext Brussels.
Arseus is a multinational group of companies that provides products, services and concepts for professionals active in the healthcare sector in 30 countries in Europe, North America, South America, Asia and Australia. Arseus is active in the markets for pharmaceutical compounding for pharmacies, medical ICT solutions, and dental, medical and surgical products and concepts.
Ger van Jeveren, CEO van Arseus: “The listing of Arseus on Euronext Brussels and Amsterdam on October 5, 2007 was an important milestone for Arseus. Both the company and the stock price have shown strong growth since the listing. Arseus has developed rapidly into a leading company with a strong focus on innovative products and concepts with substantial added value. The listing of options on the shares of our company marks a further step in Arseus’ development. We believe that this may offer shareholders an alternative financial instrument on Euronext, enhance the liquidity of our share, and increase the visibility of Arseus in the financial markets.”
Vincent Van Dessel, CEO and Chairman of Euronext Brussels: “We are pleased to announce the introduction of the Arseus options, providing investors with new investment opportunities. Arseus option class will benefit from the growing interest in Belgian options we’ve seen over the past year.”
[1] This press release was sent out by Arseus NV and Arseus BV.
Please open the link below for the press release: